Calcium acetate (CAS NO : 62-54-4)

Calcium Acetate (CAS No: 62-54-4) currently maintains a robust valuation in the global speciality chemicals market, primarily underpinned by its indispensable role as a high-affinity phosphate binder in treating hyperphosphatemia within the chronic kidney disease (CKD) patient population. Market indicating projected (CAGR) of approximately 3.4% through 2034, with the pharmaceutical-grade segment dominating over 30% of market share due to stringent pharmacopoeia compliance requirements. Beyond the clinical sector, the compound is witnessing significant diversification into the high-growth nutraceutical and food science industries, where it serves as a critical acidity regulator and preservative (E263) to inhibit rope bacteria in commercial bakery applications. Furthermore, industrial-scale demand is accelerating in the Asia-Pacific region, which is emerging as the fastest-growing hub driven by the integration of calcium acetate in advanced wastewater treatment for biological denitrification and as a high-performance corrosion inhibitor for steel and aluminium alloys in aqueous environments. As a globally established Calcium Acetate supplier with high purity levels, we ensure dependable supply, consistent quality, and complete regulatory documentation, including Calcium Acetate CoA and Calcium Acetate TDS across all grades. Beyond supply, we support partners through the entire product lifecycle from route scouting, process and formulation development, and analytical method development to scale-up, process optimisation, and pilot-to-commercial manufacturing. Our teams also assist with GMP-compliant quality assurance, regulatory documentation, and global supply chain and logistics coordination.